Visitors Now:
Total Visits:
Total Stories:
Profile image
By Global Market Insights Inc.
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Japan in Regenerative Medicine Market Driver and Trends 2015 Analysis and Forecasts to 2020

Wednesday, October 12, 2016 0:16
% of readers think this story is Fact. Add your two cents.

(Before It's News) adds “Regenerative Medicine Market in Japan 2016-2020” new report to its research database. The report spread across 102 pages with table and figures in it.

The Report analysts forecast the regenerative medicine market in Japan to grow at a CAGR of 35.3% during the period 2016-2020.

Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat damaged or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, gene therapy, and cell therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues, whereas cell therapy helps in treating the functioning of existing cells.

Browse full table of contents and data tables at

The report covers the present scenario and the growth prospects of the regenerative medicine market in Japan for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of regenerative medicine products to end-users like hospitals, ambulatory surgical centers (ASCs), and clinical research laboratories.

The market is divided into the following segments based on product:

 Tissue Scaffold

 Cell Therapy

The Report Regenerative Medicine Market in Japan 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Request a sample copy at

Key vendors
 JCR Pharmaceuticals
 Japan Tissue Engineering
 Caladrius Biosciences
 Rohto Pharmaceuticals

Other prominent vendors
 FUJISOFT Tissue Engineering
 Cyfuse Biomedical
 Irvine Scientific
 Sumitomo Dainippon
 MEDIPAL Holdings

Market driver
 Growing partnerships of MNCs with local vendors in Japan
 For a full, detailed list, view our report

Market challenge
 High cost and failure rate in clinical trials coupled with inadequate clinical evidence
 For a full, detailed list, view our report

Market trend
 Strong pipeline portfolio of regenerative medicines
 For a full, detailed list, view our report

Key questions answered in this report
 What will the market size be in 2020 and what will the growth rate be?
 What are the key market trends?
 What is driving this market?
 What are the challenges to market growth?
 Who are the key vendors in this market space?
 What are the market opportunities and threats faced by the key vendors?
 What are the strengths and weaknesses of the key vendors?

Inquiry before Buying at

To receive personalized assistance, write to us @ with the report title in the subject line along with your questions or call us at +1 866-764-2150

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.